Navigation Links
Fincor (FINC) Makes a Share Transfer and Enters the Market With ACTRx a New Malaria and Dengue Fever Treatment
Date:5/1/2009

NEW YORK and NASSAU, The Bahamas, May 1 /PRNewswire-FirstCall/ -- Fincor (Pink Sheets: FINC) through a share split with Prospero Group (Pink Sheets: PRPG), a leading company in the field of water technologies, enlarges its portfolio with the new ACTRx Malaria and Dengue fever treatment. Fincor also acquired the WETTECH and Advanced Cavitation Technologies.

Fincor, acquired a majority of ACTRx International Inc., which combines several natural drugs to fight Malaria and Dengue fever and looks to become a premier global supplier of Malaria and Dengue cures, preventatives, maintenance and information products and services.

According to the World Health Organization, over 3 billion people live in areas at risk of malaria transmission, and annually over one million deaths are attributable to it -- 90% of which are to children under the age of five. However, malaria is a preventable and treatable disease, and the United Nations has called for elimination of all malaria deaths by the end of 2015, a goal which President Obama committed the United States to supporting on April 24th, 2009. The pharmaceutical package available through ACTRx will be a strong leader in the global fight against these unnecessary deaths from malaria. Additionally, it will assist in protecting and treating the 2.5 billion people at risk from dengue fever, and the 5 million dengue infections that occur each year. Prospero Group's intention is to research, review and objectively resolve the issues that keep these diseases active in our global society.

Fincor also acquired WETTECH marketed as Prospero Water Technologies and the Advanced Cavitation Technology.

About Fincor Inc.: Fincor Inc. is a technology and pharmaceutical company. It has recently acquired ACTRx International Inc. which produces Malaria and Dengue fever drugs in order to become the premier global supplier of Malaria and Dengue cures, preventatives, maintenance and information products and services. Fincor Inc. also acquired Advanced Cavitation Technology ("WETTECH"), which produces 1000 gallons (200 liters) per hour of high purity distilled water. Using this technology, consistently delivers the highest purity product water at the lowest overall cost with a minimum of maintenance.

Allowing the liquid to become the heat source, rather than a hot surface as in conventional applications eliminates the problems of scale build-up and fouling associated with the heating of impure liquids. So the device provides efficient, simple, inexpensive and reliable sources of distilled potable water for residential, commercial and industrial use. The Cavitation Technology operates at a very low operating cost and is the only water purification of its type to be fully clean-in-place (CIP) capable at such large capacity of delivering potable water.

www.prospero-group.com


'/>"/>
SOURCE Fincor Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Web Portal Makes Organ Donation Easy
2. Advanced Cell Technologys Dr. Robert Lanza Makes List of 100 Most Inspiring People in the Life-Sciences Industry
3. NanoLogix Inc. Appoints Director of IP and Makes Progress on Rapid Anthrax Detection
4. Argonne researcher studies what makes quantum dots blink
5. Modifying an anti-cancer drug makes it more specific
6. NanoLogix, Inc. Makes Stock Pick List
7. Pharsight Makes Strong Contribution to Inaugural American Conference on Pharmacometrics
8. CSCs Dr. Robert M. Wah Makes Top 10 in 50 Most Powerful Physician Executives List
9. AMT Makes Important Advance in the Development of its Gene Therapy for Hemophilia B -Company Accesses Technology to Prevent Immune Response
10. University of Pennsylvania engineers reveal what makes diamonds slippery at the nanoscale
11. Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... ... May 25, 2016 , ... ... and Drug Administration (FDA) has granted the company’s orphan drug designation request covering ... orphan drug designation granted by the FDA. , Spinocerebellar ataxia is a ...
(Date:5/24/2016)... , ... May 24, 2016 , ... Last week, Callan ... corporate executives and entrepreneurs, held The Future of San Diego Life Science event at ... Diego life science community attended the event with speakers Dr. Rich Heyman, former CEO ...
(Date:5/23/2016)... ... 23, 2016 , ... PrecisionAg® Media has released its latest ... The paper outlines the key trends that are creating both opportunities and challenges ... lot of highs and lows as the precision agriculture market has grown and ...
(Date:5/23/2016)... and LONDON , May 23, 2016 /PRNewswire/ ... See Frontage Boost Efficiency by 40% - Frontage Implement ... - Frontage Enforce Quality, Compliance and Traceability Within the Bioanalytical lab ... labs in the United States and ... to be deployed across its laboratory facilities. In addition to serving ...
Breaking Biology Technology:
(Date:3/22/2016)... March 22, 2016 ... Sensors Market for Consumer Industry by Type (Image, ... Application (Communication & IT, Entertainment, Home Appliances, ... Forecast to 2022", published by MarketsandMarkets, the ... to reach USD 26.76 Billion by 2022, ...
(Date:3/15/2016)... -- --> --> According ... "Digital Door Lock Systems Market - Global Industry Analysis, Size, ... digital door lock systems market in terms of revenue was ... to grow at a CAGR of 31.8% during the period ... (MSMEs) across the world and high industrial activity driving inclusive ...
(Date:3/11/2016)... PUNE, India , March 11, 2016 ... to a new market research report "Image Recognition Market ... by Application (Marketing and Advertising), by Deployment Type (On-Premises ... Global Forecast To 2022", published by MarketsandMarkets, the global ... in 2015 to USD 29.98 Billion by 2020, at ...
Breaking Biology News(10 mins):